ACM
GRTX

AIGH Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

AIGH Capital Management’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,036,495
Closed -$16.5M – 64
2021
Q3 		$16.5M Buy
2,036,495
+13,606
+0.7% +$117K 3.47% 8
2021
Q2 		$19.9M Buy
2,022,889
+1,110,290
+122% +$9.02M 3.58% 4
2021
Q1 		$8.05M Buy
+912,599
New +$10M 1.69% 19

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AIGH Capital Management's GRTX Position: Q4 2021 in Review

AIGH Capital Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 2,036,495 shares — an estimated $16.5M sold.

AIGH Capital Management first reported a position in GRTX in Q1 2021 and held it in 3 quarters. The position peaked at $19.9M in Q2 2021. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

  • AIGH Capital Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • AIGH Capital Management sold 2,036,495 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $16.5M.
  • AIGH Capital Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • AIGH Capital Management's Galera Therapeutics, Inc. Common Stock position peaked at $19.9M in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on AIGH Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.